7-Isopropyl-4-methyloxepan-2-one
Common Name: |
7-Isopropyl-4-methyloxepan-2-one |
IUPAC Name: |
4-methyl-7-propan-2-yloxepan-2-one |
Molecular Formula: |
C10H18O2 |
SMILES: |
CC1CCC(OC(=O)C1)C(C)C |
Inchi: |
1S/C10H18O2/c1-7(2)9-5-4-8(3)6-10(11)12-9/h7-9H,4-6H2,1-3H3 |
Inchi Key: |
GGAXPLCKKANQED-UHFFFAOYSA-N |
Cas No: |
499-54-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
170.25 |
Mass (g/mol) |
170.131 |
Molar Refractivity |
49.35 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
1 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
247.00 to 248.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.024 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
2.374 |
iLOGP |
2.38 |
XLOGP3 |
2.73 |
WLOGP |
2.37 |
MLOGP |
2.19 |
ESOL Log S |
-2.55 |
ESOL Solubility (mg/ml) |
0.48 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.94 |
Ali Solubility (mg/ml) |
0.2 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.92 |
Silicos-IT Solubility (mg/ml) |
2.05 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.40 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.399 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.512 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |